North America Bioanalytical Testing Services Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Bioanalytical Testing Services Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Bioanalytical Testing Services Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics

5.2 Market Opportunities

5.2.1 Uninterrupted Growth of Pharmaceuticals Industry

5.3 Future Trends

5.3.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases

5.4 Impact of Drivers and Restraints

6. North America Bioanalytical Testing Services Market Regional Analysis

6.1 North America Bioanalytical Testing Services Market Overview

6.2 North America Bioanalytical Testing Services Market Revenue 2020-2030 (US$ Million)

6.3 North America Bioanalytical Testing Services Market Forecast Analysis

7. North America Bioanalytical Testing Services Market Analysis – by Services

7.1 Pharmacokinetics

7.1.1 Overview
7.1.2 Pharmacokinetics: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Biomarkers

7.2.1 Overview
7.2.2 Biomarkers: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Immunogenicity

7.3.1 Overview
7.3.2 Immunogenicity: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Virology Testing

7.4.1 Overview
7.4.2 Virology Testing: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Cell-based assays

7.5.1 Overview
7.5.2 Cell-based assays: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Bioanalytical Testing Services Market Analysis – by Disease Indication

8.1 Cardiovascular

8.1.1 Overview
8.1.2 Cardiovascular: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Neurological Disorders

8.2.1 Overview
8.2.2 Neurological Disorders: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Metabolic Disorders

8.3.1 Overview
8.3.2 Metabolic Disorders: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Autoimmune Disorders

8.4.1 Overview
8.4.2 Autoimmune Disorders: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Respiratory Diseases

8.5.1 Overview
8.5.2 Respiratory Diseases: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.6 Oncology

8.6.1 Overview
8.6.2 Oncology: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.7 Sexual Health

8.7.1 Overview
8.7.2 Sexual Health: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.8 Bone Disease

8.8.1 Overview
8.8.2 Bone Disease: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Bioanalytical Testing Services Market Analysis – by End User

9.1 Pharmaceutical and Biopharmaceutical Companies

9.1.1 Overview
9.1.2 Bone Disease: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Contract Research Organization

9.2.1 Overview
9.2.2 Bone Disease: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Contract Development And Manufacturing Organization

9.3.1 Overview
9.3.2 Bone Disease: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Bioanalytical Testing Services Market – North America Analysis

10.1 North America

10.1.1 North America Bioanalytical Testing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Bioanalytical Testing Services Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Bioanalytical Testing Services Market Breakdown, by Services
10.1.1.1.2 US: North America Bioanalytical Testing Services Market Breakdown, by Disease Indication
10.1.1.1.3 US: North America Bioanalytical Testing Services Market Breakdown, by End User

10.1.1.2 Canada: North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Bioanalytical Testing Services Market Breakdown, by Services
10.1.1.2.2 Canada: North America Bioanalytical Testing Services Market Breakdown, by Disease Indication
10.1.1.2.3 Canada: North America Bioanalytical Testing Services Market Breakdown, by End User

10.1.1.3 Mexico : North America Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Bioanalytical Testing Services Market Breakdown, by Services
10.1.1.3.2 Mexico : North America Bioanalytical Testing Services Market Breakdown, by Disease Indication
10.1.1.3.3 Mexico : North America Bioanalytical Testing Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Bioanalytical Testing Services Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 SGS SA

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Pharmaron Beijing Co Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Element Materials Technology Group Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 CD BioSciences Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Charles River Laboratories International Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Eurofins Scientific SE

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Labcorp Drug Development Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Syneos Health Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 KCAS BioanalyticalBiomarker Services LLC

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 ICON Plc,

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Intertek Group Plc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights